Applicant, as named in the Orange Book

Javelin Pharms Inc

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis

None.

Dyloject · Enters 12-month window basis: patent, carve-out possibleListed date 22 Mar 2027Detected 24 Oct 2026